Search PubMed⌕ Search

Biomedical subjects

Y Uchimura

Publications and source records attributed to Y Uchimura.

45 records · Page 3Linked to original sources
PubMed1982

Unusual personal identification with characteristic features in chest roentgenograms.

This case illustrates the unexpected aspects of radiographic personal identification. A skeletonized body without the neck and head, upper extremities, and feet was discovered on a seashore. No positive results were obtained from the remains concerning either the cause of death, the manner of death, or precise identification of the body. Roentgenologic examinations of the remains revealed a marked eminence of the manubrium sterni with characteristic crossing shadows. A successful partial superimposition of the ante- and postmortem lateral chest x-ray films helped to place the personal identification as that of a fisherman, 58 years old, missing in the sea for 21 days.

Forensic Medicine↗
PubMed1980

Puffer poisoning in Japan--a case report.

A fatal case of puffer poisoning in an 80-year-old man is reported. By using a bioassay with mice and extracts of crude poisons, the toxicities of the autopsy materials, fresh puffer ovaries, and the remaining cooked ovaries were determined and expressed in mouse units per gram (M.U.). Some medicolegal aspects of puffer poisoning are also discussed. Puffer poisoning is a primary cause of fatal food poisoning in Japan even though its frequency is not high.

Adult↗
PubMedDate not supplied

The influence of putrefactive changes on the determination of Paraquat in autopsy materials.

This paper describes how the putrefactive changes in a cadaver will influence the determination of Paraquat in autopsy material. The carcasses of rats that had been given large doses of Paraquat and subsequently killed by cervical dislocation, were left at room temperature for up to seven days. Samples of stomach, caecum and liver were removed for the colorimetric determination of Paraquat with sodium dithionite following extraction on a Dowex 50W-4 column. Paraquat recovered from the stomach and caecum showed a decrease with time after death with the rate of decrease being greater in the caecum samples. However, the concentration of Paraquat in the liver increased for three days and then began to decrease gradually. The possible causes of these variations in Paraquat recovery are discussed. The findings appear to demonstrate the value of Paraquat determination even in samples from material that is in a state of advanced putrefaction.

Animals↗
PubMedDate not supplied

Long-term follow-up of interferon-treated chronic hepatitis C and serum hepatic fibrosis markers.

BACKGROUND/AIMS: We investigated the clinical application of serum fibrosis markers in a long-term follow-up of patients with chronic hepatitis C treated with interferon-alpha. METHODOLOGY: This study included 52 patients treated with interferon-alpha (total: 480 MU) for 6 months. They each underwent liver biopsy before and after treatment. Twenty-eight patients who underwent liver biopsy less than 2 years after treatment were classified as group 1, and 24 patients as group 2. The two groups were subdivided into HCV RNA-negative responders and HCV RNA-positive nonresponders. Liver specimens were estimated using grading and staging scores. Serum hyaluronan, PIIIP, and type IV collagen levels were measured before and after treatment. RESULTS: In the responders of groups 1 and 2, grading score after treatment was significantly decreased compared with that before treatment. Staging score after treatment was significantly improved only in the responders of group 2. In the responders of group 2, serum hyaluronan level was significantly decreased compared with that before treatment. In group 2, the grading score was significantly correlated with serum PIIIP and type IV collagen levels, and the staging score was significantly correlated with only serum hyaluronan level. CONCLUSIONS: These findings indicate that the serum PIIIP and type IV collagen levels reflect the activity, and serum hyaluronan reflects the degree of fibrosis in liver specimens of HCV RNA-negative patients in a long-term follow-up of patients after interferon-alpha treatment.

Adult↗
PubMedDate not supplied

The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment.

To determine whether serum hepatitis C virus (HCV) RNA disappearance after interferon (IFN) treatment prevents development of hepatocellular carcinoma (HCC), we evaluated retrospectively the incidence of HCC in patients with chronic hepatitis C. A total of 213 patients were monitored for more than 6 months after completion of IFN treatment. Sixty-three of the 213 patients (29.6%) achieved a complete response (CR) to treatment and 150 (70.4%) had no response (NR). HCC developed in 12 (5.6%), all of whom were NR. Logistic analysis showed age, alpha -fetoprotein, and staging of histological finding before IFN treatment were independent factors to development of HCC. The fact that there was no HCC development from CR provides a basis for IFN treatment in chronic HCV infection.

Adult↗
PubMedDate not supplied

Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?

During the course of long-term follow-up, we examined the efficacy of interferon (IFN) in the improvement of liver function and prevention of hepatocellular carcinoma (HCC) in hepatitis C virus (HCV) associated cirrhosis patients. Fifty-five cirrhotic patients, in whom HCC nodules in the liver were not detected by ultrasonography (US) or computed tomography (CT), received 3 or 6 million units of human lymphoblastoid IFN daily for two weeks and 3 times a week for 22 weeks. Complete response (CR) was defined as normalization of serum alanine aminotransferase (ALT) together with negative HCV RNA at 6 months after IFN therapy completion. Any other pattern of response was defined as non-response (NR). After IFN therapy the patients were followed up every 1-3 months for at least 1 year (average follow-up period, about 40 months) with serological tests and US or CT. In the 8 CR patients, the serum ALT levels remained normal and HCV RNA remained negative. Platelet count, white blood cell count, serum albumin and zinc turbidity test have recovered to the normal range at final follow-up. Ten of the 47 patients with NR have developed HCC, whereas no patients with CR has developed HCC during follow-up. We conclude that IFN improves the liver function and may prevent the development of HCC even in cirrhotic patients who show CR to IFN therapy.

Carcinoma, Hepatocellular↗